Comparison of Performance in Biostatistics and Epidemiology across USMLE Steps 1, 2, and 3 D Swanson, W Ouyang K Holtzman, M Johnson, and S Haist
|
|
- Aileen Jennings
- 5 years ago
- Views:
Transcription
1 Comparison of Performance in Biostatistics and Epidemiology across USMLE Steps 1, 2, and 3 D Swanson, W Ouyang K Holtzman, M Johnson, and S Haist National Board of Medical Examiners Philadelphia, PA
2 Purpose of Study Several years ago, the Committee to Evaluate the USMLE Program (CEUP) recommended introduction of a testing format designed to assess an examinee s ability to engage in evidence-based decision making. This study was conducted to obtain baseline information about examinees performance in biostatistics and epidemiology as they progress through USMLE.
3 Method: Test Material and Subjects Test Material 139 (unscored) biostatistics and epidemiology items 77 used on Steps 1, 2CK, 3 62 used on Steps 2CK, 3 Procedure Small number of study items randomly selected for each examinee Subjects First-time takers from LCME schools taking Step exams in Median number of examinees/item: Step 1: 225 Step 2 CK: 557 Step 3: 395
4 Number Needed to Treat A trial of a new lipid-lowering drug is conducted in a population of patients aged 60 years and older. The drug has been designed to decrease the risk for myocardial infarction (MI). The study participants have multiple risk factors for cardiovascular disease. After 3 years of treatment, the incidence of MI in the intervention group is 2% compared with 10% in the control group (p<0.05). Based on these data, which of the following best represents the number of patients who must be treated with this drug for 3 years to prevent one MI? (A) 6.25 (B) 12.5 (C) (D) 25 (E) 50 Exam p-value biserial Step Step 2 CK Step SCBQ0836
5 Flaws in Study Design Investigators are conducting a study of a community-level intervention to reduce body mass index (BMI) among school-age children. Forty-eight communities are considered for the study, but only 24 of these communities meet the criteria that the investigators have chosen, including similar population sizes, median incomes, and proportions of total area that are devoted to recreation. These 24 communities are then randomly assigned to intervention status or control status. Changes in the BMIs of 100 randomly selected children in each town are measured by trained research assistants who are blinded to community assignment. The results favor the intervention by a statistically and clinically significant margin. The conclusion by the investigators that the intervention should be implemented in communities across the United States is most likely to be criticized on which of the following grounds? (A) Ascertainment bias (B) Generalizability (C) Inappropriate control group (D) Recall bias (E) Selection bias Exam p-value biserial Step 2 CK Step SCBq0896
6 Exam Item Difficulty and Discrimination Number of Items by Step Median Item Difficulty (p-value) Median Item Discrimination (biserial) Step Step 2 CK Step Step 2 CK Step
7 Item Difficulties (p-values): Step 2 CK vs Step 1 Better performance on Step 2 CK Better performance on Step 1
8 Item Difficulties (p-values): Step 3 vs Step 1 Better performance on Step 3 Better performance on Step 1
9 Item Difficulties (p-values): Step 3 vs Step 2 CK Better performance on Step 3 Better performance on Step 2 CK
10 Results of Matched-Pairs t-tests on Logit-Transformed Item Difficulties Exams Compared # of Items Correlation t-test Signif Step 1 and Step 2 CK NS Step 1 and Step p < Step 2 CK and Step p < 0.002
11 Summary of Results and Areas of Declining Performance Overall performance declined 1.5% (non-significant) from Step 1 to Step 2 CK 1.5% further decline from Step 2 CK to Step 3 Review of item content indicated performance declines were largest for items on: Sensitivity, specificity, and predicted value Health impact (risk/benefit)
12 10 Basic Science Retention: NBME Research from 1975 to Behav Sci Path Total Biochem Micro Anat Phys Pharm Step Step 3
13 Discussion Glass half-empty or half-full? Observed performance declines in biostatistics and epidemiology were small relative to most other basic science areas Reasons for the decline are unclear Biostatistics/epidemiology may be learned primarily during undergraduate medical education Topics may receive little (or variable) emphasis during graduate education
14 Limitations Extensive preparation for the high-stakes Step 1 may inflate baseline performance creating a false impression of decline Relatively small samples of biostatistics and epidemiology items were used in some content areas Use of a cross-sectional design in the study weakens the inferences that can be drawn Reliance on an MCQ format limits how understanding of biostatistics and epidemilogy content can be assessed No analyses have yet been done to identify school characteristics mediating the magnitude of performance shifts
15 Drug Ad Format 1 Which of the following statements most accurately summarizes the effect of Estabile on weight loss? (A) Weight loss is more likely in patients taking Estabile than in patients taking a placebo (B) Weight loss is less likely in patients taking Estabile than in patients taking a placebo (C) Expected weight loss in patients taking Estabile is greater than in patients taking a placebo (D) Expected weight loss in patients taking Estabile is less than in patients taking a placebo (E) Weight loss in patients taking Estabile is no different than in patients taking placebo 2 Which of the following prescriptions for Estabile would be considered an off label use of the medication? (A) For an adult with type 1 diabetes mellitus (B) For a child with type 2 diabetes mellitus (C) Administration by the subcutaneous route (D) Administration twice daily 3 In a randomized controlled clinical trial performed to gain FDA approval for Estabile for the treatment of hyperglycemia in patients with type1 diabetes mellitus, which of the following is the most appropriate treatment for control participants? (A) Placebo (B) Diet and exercise (C) Oral anti-diabetic medication (D) Regular insulin
16 Abstract Format Please answer the questions below based on the abstract shown (Kernan et al, Phenylpropanolamine and the risk of hemorrhagic stroke, NEJM 2000; 343: Background: Phenylpropanolamine (PPA) is commonly found in appetite suppressants and cough or cold remedies. Case reports have linked the use of products containing PPA to hemorrhagic stroke, often after the first use of these products. To study the association, we designed a casecontrol study Methods: Men and women 18 to 49 years of age were recruited from 43 U.S. hospitals. Eligibility criteria included the occurrence of a subarachnoid or intracerebral hemorrhage within 30 days before enrollment and the absence of a previously diagnosed brain lesion. Random-digit dialing identified two matched control subjects per patient. Results: There were 702 patients and 1376 control subjects. For women, the adjusted odds ratio was (95 percent confidence interval, 1.51 to ; P=0.02) for the association between the use of appetite suppressants containing PPA and the risk of hemorrhagic stroke and 3.13 (95 percent confidence interval, 0.86 to 11.46; P=0.08) for the association with the first use of a product containing PPA. All first uses of PPA involved cough or cold remedies. For men and women combined, the adjusted odds ratio was 1.49 (95 percent confidence interval, 0.84 to 2.64; P=0.17) for the association between the use of a product containing PPA and the risk of hemorrhagic stroke, 1.23 (95 percent confidence interval, 0.68 to 2.24; P=0.49) for the association with the use of cough or cold remedies that contained PPA, and (95 percent confidence interval, 1.38 to ; P=0.03) for the association with the use of appetite suppressants that contained PPA. An analysis in men showed no increased risk of hemorrhagic stroke in association with the use of cough or cold remedies containing PPA. No men reported the use of appetite suppressants. Conclusions: The results suggest that PPA in appetite suppressants, and possibly in cough and cold remedies, is an independent risk factor for hemorrhagic stroke in women. 1. Which of the following is of most concern regarding the validity of the conclusions reported in this study? (A) Children were excluded from the study (B) Hemorrhagic stroke preceded exposure to PPA (C) No men reported the use of appetite suppressants (D) There are more controls than cases in the study (E) There was inaccurate reporting of PPA intake by study participants 2. The reported 95% confidence interval for the adjusted odds ratio for the association between PPA use as an appetite suppressant and hemorrhagic stroke in women is most consistent with which of the following? (A) Large standard deviation for the odds ratio estimate (B) Statistically nonsignificant result (C) True odds ratio of 1.27 for the described association (D) Decreased risk for hemorrhagic stroke in women using PPA as an appetite suppressant (E) Study underpowered to detect an effect of PPA on hemorrhagic stroke 3. Which of the following can be calculated based on the data presented in this study abstract? (A) The number of women exposed to PPA for one additional hemorrhagic stroke to occur (B) The number of first uses of PPA that involved appetite suppressants (C) The relative risk increase for hemorrhagic stroke associated with PPA use in women (D) The proportion of hemorrhagic strokes observed in men in the study (E) The proportion of PPA use that involved cough and cold remedies
Flaws, Bias, Misinterpretation and Fraud in Randomized Clinical Trials
Flaws, Bias, Misinterpretation and Fraud in Randomized Clinical Trials Steven E. Nissen MD Chairman, Department of Cardiovascular Medicine Cleveland Clinic Disclosure Consulting: Many pharmaceutical companies
More informationAssessing Cardiovascular risk in different populations
A-1 Assessing Cardiovascular risk in different populations Murray Stewart (GSK) A-2 Studies with RSG across different risk population Short term studies low risk ADOPT newly diagnosed low risk DREAM IGT
More informationEpidemiological study design. Paul Pharoah Department of Public Health and Primary Care
Epidemiological study design Paul Pharoah Department of Public Health and Primary Care Molecules What/why? Organelles Cells Tissues Organs Clinical medicine Individuals Public health medicine Populations
More informationJAMA. 2011;305(24): Nora A. Kalagi, MSc
JAMA. 2011;305(24):2556-2564 By Nora A. Kalagi, MSc Cardiovascular disease (CVD) is the number one cause of mortality and morbidity world wide Reducing high blood cholesterol which is a risk factor for
More informationOnline Supplementary Material
Section 1. Adapted Newcastle-Ottawa Scale The adaptation consisted of allowing case-control studies to earn a star when the case definition is based on record linkage, to liken the evaluation of case-control
More informationADVANCE post trial ObservatioNal Study
Hot Topics in Diabetes 50 th EASD, Vienna 2014 ADVANCE post trial ObservatioNal Study Sophia Zoungas The George Institute The University of Sydney Rationale and Study Design Sophia Zoungas The George Institute
More informationIs There An Association?
Is There An Association? Exposure (Risk Factor) Outcome Exposures Risk factors Preventive measures Management strategy Independent variables Outcomes Dependent variable Disease occurrence Lack of exercise
More informationAP Statistics Chapter 5 Multiple Choice
AP Statistics Chapter 5 Multiple Choice 1. A nutritionist wants to study the effect of storage time (6, 12, and 18 months) on the amount of vitamin C present in freeze dried fruit when stored for these
More informationCritical Appraisal Series
Definition for therapeutic study Terms Definitions Study design section Observational descriptive studies Observational analytical studies Experimental studies Pragmatic trial Cluster trial Researcher
More informationGuidance Document for Claims Based on Non-Inferiority Trials
Guidance Document for Claims Based on Non-Inferiority Trials February 2013 1 Non-Inferiority Trials Checklist Item No Checklist Item (clients can use this tool to help make decisions regarding use of non-inferiority
More informationILLUMINATE. Effects of torcetrapib in patients at high risk for coronary events NEJM. 2007; 357:
ILLUMINATE. Effects of torcetrapib in patients at high risk for coronary events NEJM. 2007; 357: 2109-2122. ILLUMINATE The most important trial since 2000? Background Inhibition of cholesteryl ester transfer
More informationHandout 1: Introduction to the Research Process and Study Design STAT 335 Fall 2016
DESIGNING OBSERVATIONAL STUDIES As we have discussed, for the purpose of establishing cause-and-effect relationships, observational studies have a distinct disadvantage in comparison to randomized comparative
More informationUse Survey Happiness Complete. SAV file on Blackboard Assigned to Mistake 8
Deborah Hughis Final Exam 9802 Dr. Morote Use Survey Happiness Complete. SAV file on Blackboard Assigned to Mistake 8 (We were given individualized data from files and had to analyze them to complete the
More informationHow to Make Sense of Statistics Reported in the Medical Literature
How to Make Sense of Statistics Reported in the Medical Literature Colin P. West, MD, PhD Division of General Internal Medicine Division of Biomedical Statistics and Informatics Denise M. Dupras, MD, PhD
More informationBiostatistics and Epidemiology Step 1 Sample Questions Set 1
Biostatistics and Epidemiology Step 1 Sample Questions Set 1 1. A study wishes to assess birth characteristics in a population. Which of the following variables describes the appropriate measurement scale
More informationFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial. Joseph P. Broderick, MD James Grotta, MD Jordan Elm, PhD
FVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial Joseph P. Broderick, MD James Grotta, MD Jordan Elm, PhD Background Intracerebral hemorrhage (ICH) accounts for more than
More informationHae Sun Suh, B.Pharm., Ph.D. Jason N. Doctor, Ph.D.
Podium Presentation, May 18, 2009 Comparison of Cardiovascular Event Rates in Subjects with Type II Diabetes Mellitus who Augmented from Statin Monotherapy to Statin Plus Fibrate Combination Therapy with
More informationExperimental and survey design
Friday, October 12, 2001 Page: 1 Experimental and survey design 1. There is a positive association between the number of drownings and ice cream sales. This is an example of an association likely caused
More informationPHP2500: Introduction to Biostatistics. Lecture III: Introduction to Probability
PHP2500: Introduction to Biostatistics Lecture III: Introduction to Probability 1 . 2 Example: 40% of adults aged 40-74 in Rhode Island have pre-diabetes, a condition that raises the risk of type 2 diabetes,
More informationIncorporating Clinical Information into the Label
ECC Population Health Group LLC expertise-driven consulting in global maternal-child health & pharmacoepidemiology Incorporating Clinical Information into the Label Labels without Categories: A Workshop
More informationLATE BREAKING STUDIES IN DM AND CAD. Will this change the guidelines?
LATE BREAKING STUDIES IN DM AND CAD Will this change the guidelines? Objectives 1. Discuss current guidelines for prevention of CHD in diabetes. 2. Discuss the FDA Guidance for Industry regarding evaluating
More informationClinical Trial Synopsis TL-OPI-518, NCT#
Clinical Trial Synopsis, NCT# 00225264 Title of Study: A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl vs Glimepiride
More informationGRADE for reducing adversegrade for reducing adverse outcomes. outcomes
outcomes GRADE for reducing adversegrade for reducing adverse outcomes actions to reduce adverse outcomes should be based on confidence in estimates of effect GRADE provides detailed guidance for assessing
More informationSupplement DS1 Search strategy. EMBASE Search Strategy
British Journal of Psychiatry doi: 10.1192/bjp.bp.111.106666 Vitamin D deficiency and depression in adults: systematic review and meta-analysis Rebecca E. S. Anglin, Zainab Samaan, Stephen D. Walter and
More information1. How does the response to therapy compare in elderly versus middle age adults with diabetes in a randomized trial?
Jeff D. Williamson, MD, MHS Chief, Geriatric Medicine Sticht Center on Aging 1. How does the response to therapy compare in elderly versus middle age adults with diabetes in a randomized trial? 2. Are
More informationObservational Study Designs. Review. Today. Measures of disease occurrence. Cohort Studies
Observational Study Designs Denise Boudreau, PhD Center for Health Studies Group Health Cooperative Today Review cohort studies Case-control studies Design Identifying cases and controls Measuring exposure
More informationChapter 5: Producing Data Review Sheet
Review Sheet 1. In order to assess the effects of exercise on reducing cholesterol, a researcher sampled 50 people from a local gym who exercised regularly and 50 people from the surrounding community
More informationChapter 6. Experiments in the Real World. Chapter 6 1
Chapter 6 Experiments in the Real World Chapter 6 1 Thought Question 1 Suppose you are interested in determining if drinking a glass of red wine each day helps prevent heartburn. You recruit 40 adults
More informationPractice Quiz for Chapter 1
Practice Quiz for Chapter 1 1. Giving half the members of a group some purported psychological finding and the other half an opposite result is an easy way to demonstrate the impact of A. the false consensus
More informationProtocol Development: The Guiding Light of Any Clinical Study
Protocol Development: The Guiding Light of Any Clinical Study Susan G. Fisher, Ph.D. Chair, Department of Clinical Sciences 1 Introduction Importance/ relevance/ gaps in knowledge Specific purpose of the
More information3. Screening Subject Identification Screening Overview
3. Screening 3.1 Subject Identification Each site will be responsible for identifying and recruiting participants into the study. It is known that screening methods vary across sites. It is, however, important
More informationJournal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study
Journal Club Articles for Discussion Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995 Dec
More informationBRL /RSD-101RLL/1/CPMS-716. Report Synopsis
Report Synopsis Study Title: A Multicenter, Open-label, Six-Month Extension Study to Assess the Long-term Safety of Paroxetine in Children and Adolescents with Major Depressive Disorder (MDD) or Obsessive-Compulsive
More informationMain objective of Epidemiology. Statistical Inference. Statistical Inference: Example. Statistical Inference: Example
Main objective of Epidemiology Inference to a population Example: Treatment of hypertension: Research question (hypothesis): Is treatment A better than treatment B for patients with hypertension? Study
More informationChapter 4 Review. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question.
Name: Class: Date: Chapter 4 Review Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Use Scenario 4-1. The newspaper asks you to comment on their survey
More informationSampling. (James Madison University) January 9, / 13
Sampling The population is the entire group of individuals about which we want information. A sample is a part of the population from which we actually collect information. A sampling design describes
More informationCRITICALLY APPRAISED PAPER (CAP)
CRITICALLY APPRAISED PAPER (CAP) Dahl, A., Askim, T., Stock, R., Langørgen, E., Lydersen, S., & Indredavik, B. (2008). Short- and long-term outcome of constraint-induced movement therapy after stroke:
More informationIMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS
IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS Dr Bidhu Mohapatra, MBBS, MD, FRACP Consultant Physician Endocrinology and General Medicine Introduction 382 million people affected by diabetes
More informationImproving Medical Statistics and Interpretation of Clinical Trials
Improving Medical Statistics and Interpretation of Clinical Trials 1 ALLHAT Trial & ALLHAT Meta-Analysis Critique Table of Contents ALLHAT Trial Critique- Overview p 2-4 Critique Of The Flawed Meta-Analysis
More informationthe standard deviation (SD) is a measure of how much dispersion exists from the mean SD = square root (variance)
Normal distribution The normal distribution is also known as the Gaussian distribution or 'bell-shaped' distribution. It describes the spread of many biological and clinical measurements Properties of
More informationDetecting Suspect Examinees: An Application of Differential Person Functioning Analysis. Russell W. Smith Susan L. Davis-Becker
Detecting Suspect Examinees: An Application of Differential Person Functioning Analysis Russell W. Smith Susan L. Davis-Becker Alpine Testing Solutions Paper presented at the annual conference of the National
More informationBRL /RSD-101C0D/1/CPMS-704. Report Synopsis
Report Synopsis Study Title: A Randomized, Multicenter, 10-Week, Double-Blind, Placebo- Controlled, Flexible-Dose Study to Evaluate the Efficacy and Safety of Paroxetine in Children and Adolescents with
More informationCRITICAL APPRAISAL OF MEDICAL LITERATURE. Samuel Iff ISPM Bern
CRITICAL APPRAISAL OF MEDICAL LITERATURE Samuel Iff ISPM Bern siff@ispm.unibe.ch Contents Study designs Asking good questions Pitfalls in clinical studies How to assess validity (RCT) Conclusion Step-by-step
More informationTargeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study
Targeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford
More informationMyocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
More informationModule 5. The Epidemiological Basis of Randomised Controlled Trials. Landon Myer School of Public Health & Family Medicine, University of Cape Town
Module 5 The Epidemiological Basis of Randomised Controlled Trials Landon Myer School of Public Health & Family Medicine, University of Cape Town Introduction The Randomised Controlled Trial (RCT) is the
More informationa) Is it reasonable to compute the relative risk for endometrial cancer? Explain. b) Can we estimate relative risk for heart attacks? Explain.
1. A 1980 study investigated the relationship between the use of oral contraceptives and the development of endometrial cancer. It was found that of 117 endometrial cancer patients, 6 had used oral contraceptives
More informationMixed Methods Study Design
1 Mixed Methods Study Design Kurt C. Stange, MD, PhD Professor of Family Medicine, Epidemiology & Biostatistics, Oncology and Sociology Case Western Reserve University 1. Approaches 1, 2 a. Qualitative
More informationIntroduction, Evidence, and Sampling
Motivation: Why analyze data? Introduction, Evidence, and Sampling Clinical trials/drug development: compare existing treatments with new methods Agriculture: enhance crop yields, improve pest resistance
More informationDiabetes Mellitus Type 2 Evidence-Based Drivers
This module is supported by an unrestricted educational grant by Aventis Pharmaceuticals Education Center. Copyright 2003 1 Diabetes Mellitus Type 2 Evidence-Based Drivers Driver One: Reducing blood glucose
More informationPage # 1. Objectives. History of Clinical Trials. Developing New Therapies Clinical Studies and Trials. FDA Classification of Clinical Studies/Trials
Developing New Therapies Clinical Studies and Trials Richard C. Eastman M.D. Objectives Discuss how new treatments are studied in humans. Explain how the rights of human volunteers are safeguarded. Discuss
More informationSYNOPSIS. Risperidone-R064766: Clinical Study Report RIS-USA-232 (FOR NATIONAL AUTHORITY USE ONLY)
SYNOPSIS Protocol No.: RIS-USA-232 Title of Study: Efficacy and Safety of a Flexible Dose of Risperidone Versus Placebo in the Treatment of Psychosis of Alzheimer's Disease Principal Investigator: M.D.
More informationEPIDEMIOLOGY-BIOSTATISTICS EXAM Midterm 2004 PRINT YOUR LEGAL NAME:
EPIDEMIOLOGY-BIOSTATISTICS EXAM Midterm 2004 PRINT YOUR LEGAL NAME: Instructions: This exam is 20% of your course grade. The maximum number of points for the course is 1,000; hence, this exam is worth
More informationTrial Designs. Professor Peter Cameron
Trial Designs Professor Peter Cameron OVERVIEW Review of Observational methods Principles of experimental design applied to observational studies Population Selection Looking for bias Inference Analysis
More informationCRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY FACULTY OF MEDICINE ABSTRACT DOCTORAL THESIS
CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY FACULTY OF MEDICINE ABSTRACT DOCTORAL THESIS RISK FACTORS IN THE EMERGENCE OF POSTOPERATIVE RENAL FAILURE, IMPACT OF TREATMENT WITH ACE INHIBITORS Scientific
More informationUPDATES FROM THE 2018 ANTIPLATELET GUIDELINES
UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES Claudia Bucci BScPhm, PharmD Clinical Coordinator, Cardiovascular Diseases Sunnybrook Health Sciences Centre 21st Annual Contemporary Therapeutic Issues in
More information115 remained abstinent. 140 remained abstinent. Relapsed Remained abstinent Total
Chapter 10 Exercises 1. Intent-to-treat analysis: Example 1 In a randomized controlled trial to determine whether the nicotine patch reduces the risk of relapse among smokers who have committed to quit,
More informationSYNOPSIS. Publications No publications at the time of writing this report.
Drug product: TOPROL-XL Drug substance(s): Metoprolol succinate Study code: D4020C00033 (307A) Date: 8 February 2006 SYNOPSIS Dose Ranging, Safety and Tolerability of TOPROL-XL (metoprolol succinate) Extended-release
More informationHARM. Definition modified from the IHI definition of Harm by the QUEST Harm Workgroup
Indonesia Clinical epidemiology and Evidence Based Medicine (ICE(ICE-EBM) HARM Jarir At Thobari (FK UGM) Efficacious Medical intervention Harm HARM Unintended physical injury resulting from or contributed
More informationUpdate on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient
Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient Steven E. Nissen MD Chairman, Department of Cardiovascular Medicine Cleveland Clinic Disclosure Consulting: Many pharmaceutical
More informationBenefit-Risk Assessment via Case Studies: Key Considerations & Best Practices
Benefit-Risk Assessment via Case Studies: Key Considerations & Best Practices George Quartey (PhD), Genentech Inc. (Acknowledgements: Qi Jiang, Amgen & Weili He, Merck) EFSPI Regulatory Statistics Meeting,
More informationTypes of Studies. There are three main types of studies. These are ways to collect data.
Types of Studies There are three main types of studies. These are ways to collect data. Planned / designed experiments Observational studies Sample survey STA305 - week 1 1 Planned / Designed Experiments
More informationTypes of Biomedical Research
INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH Sakda Arj Ong Vallipakorn, MD MSIT, MA (Information Science) Pediatrics, Pediatric Cardiology Emergency Medicine, Ped Emergency Family Medicine Section of
More information2.0 Synopsis. Choline fenofibrate capsules (ABT-335) M Clinical Study Report R&D/06/772. (For National Authority Use Only) Name of Study Drug:
2.0 Synopsis Abbott Laboratories Individual Study Table Referring to Part of Dossier: (For National Authority Use Only) Name of Study Drug: Volume: Choline Fenofibrate (335) Name of Active Ingredient:
More informationThe Effect of Option Homogeneity in Multiple- Choice Items
Manuscripts The Effect of Option Homogeneity in Multiple- Choice Items Applied Psychological Measurement 1 12 Ó The Author(s) 2018 Reprints and permissions: sagepub.com/journalspermissions.nav DOI: 10.1177/0146621618770803
More informationWAKE-UP has received funding from the European Union Seventh Framework Programme (FP7/ ) under grant agreement n
Intravenous Thrombombolysis in Stroke Patients with Unknown Time of Onset Results of the Multicentre, Randomized, Double-blind, Placebo- Controlled WAKE-UP Trial G. Thomalla, C.Z. Simonsen, F. Boutitie,
More informationBasic Biostatistics. Dr. Kiran Chaudhary Dr. Mina Chandra
Basic Biostatistics Dr. Kiran Chaudhary Dr. Mina Chandra Overview 1.Importance of Biostatistics 2.Biological Variations, Uncertainties and Sources of uncertainties 3.Terms- Population/Sample, Validity/
More informationMCQ and EMI Self Test
Common Foundation Programme 2002-3 Research and Critical Skills 8b 26 November 2002 MCQ and EMI Self Test At St. George's we use two types of automatically marked question. We use multiple choice questions
More informationSLENDESTA POTATO EXTRACT PROMOTES SATIETY IN HEALTHY HUMAN SUBJECTS: IOWA STATE UNIVERSITY STUDY Sheila Dana, Michael Louie, Ph.D. and Jiang Hu, Ph.D.
SLENDESTA POTATO EXTRACT PROMOTES SATIETY IN HEALTHY HUMAN SUBJECTS: IOWA STATE UNIVERSITY STUDY Sheila Dana, Michael Louie, Ph.D. and Jiang Hu, Ph.D. INTRODUCTION KEY CONCLUSIONS Excessive calorie intake
More informationThe Latest Generation of Clinical
The Latest Generation of Clinical Guidelines: HTN and HLD Dave Brackett Clinical Guideline Purpose Uniform approach Awareness of key details Diagnosis Treatment Monitoring Evidence based approach Inform
More informationGLP-1 receptor agonists for type 2 diabetes currently available in the U.S.
GLP-1 receptor agonists for type 2 diabetes currently available in the U.S. GLP-1 agonists are a class of antidiabetic agents that mimic the actions of the glucagon-like peptide. GLP-1 is one of several
More informationObservational the researcher collects information on attributes or measurements of interest but DOES NOT influence the results.
Distinction between Observational and Experimental Studies Observational the researcher collects information on attributes or measurements of interest but DOES NOT influence the results. Experimental the
More informationClinical Research Design and Conduction
Clinical Research Design and Conduction Study Design M Mohsen Ibrahim, MD Cardiac Department Cairo University Algorithm for classification of types of clinical research Grimes DA and Schulz KF. Lancet
More informationEmpirical Tools of Public Finance. 131 Undergraduate Public Economics Emmanuel Saez UC Berkeley
Empirical Tools of Public Finance 131 Undergraduate Public Economics Emmanuel Saez UC Berkeley 1 DEFINITIONS Empirical public finance: The use of data and statistical methods to measure the impact of government
More informationFactorial Study Design 07/18/12
Disclaimer: The following information is fictional and is only intended for the purposes of illustrating key concepts for results data entry in the Protocol Registration System (PRS). Example Factorial
More informationIndividual Study Table Referring to Item of the Submission: Volume: Page:
2.0 Synopsis Name of Company: Abbott Laboratories Name of Study Drug: Meridia Name of Active Ingredient: Sibutramine hydrochloride monohydrate Individual Study Table Referring to Item of the Submission:
More informationIs TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry
Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry E Van Belle, E Teiger, F Juthier, A Vincentelli, B Iung, H Eltchaninoff, J Fajadet,
More informationUnit 1 Exploring and Understanding Data
Unit 1 Exploring and Understanding Data Area Principle Bar Chart Boxplot Conditional Distribution Dotplot Empirical Rule Five Number Summary Frequency Distribution Frequency Polygon Histogram Interquartile
More informationConfounding Bias: Stratification
OUTLINE: Confounding- cont. Generalizability Reproducibility Effect modification Confounding Bias: Stratification Example 1: Association between place of residence & Chronic bronchitis Residence Chronic
More informationResults & Statistics: Description and Correlation. I. Scales of Measurement A Review
Results & Statistics: Description and Correlation The description and presentation of results involves a number of topics. These include scales of measurement, descriptive statistics used to summarize
More informationClinicalTrials.gov Identifier: NCT Sponsor/company: Sanofi-Aventis. Date: 08/02/ 2008
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: Sanofi-Aventis ClinicalTrials.gov
More informationPractical Strategies for the Clinical Use of Incretin Mimetics CME/CE. CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010
Practical Strategies for the Clinical Use of Incretin Mimetics CME/CE Robert R. Henry, MD Authors and Disclosures CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010 Introduction Type 2 diabetes
More informationQuantitative Literacy: Thinking Between the Lines
Quantitative Literacy: Thinking Between the Lines Crauder, Noell, Evans, Johnson Chapter 6: Statistics 2013 W. H. Freeman and Company 1 Chapter 6: Statistics Lesson Plan Data summary and presentation:
More informationClinical Evidence: Asking the Question and Understanding the Answer. Keeping Up to Date. Keeping Up to Date
Clinical Evidence: Asking the Question and Understanding the Answer Keeping Up to Date 5,000? per day 1,500 per day 95 per day Keeping Up to Date 5,000? per day 1,500 per day 95 per day 1 Bias Bias refers
More information(true) Disease Condition Test + Total + a. a + b True Positive False Positive c. c + d False Negative True Negative Total a + c b + d a + b + c + d
Biostatistics and Research Design in Dentistry Reading Assignment Measuring the accuracy of diagnostic procedures and Using sensitivity and specificity to revise probabilities, in Chapter 12 of Dawson
More informationCo-occurring Psychosocial Health Disparities and ARV Medication Adherence among Indigent HIV-positive Patients who Use Drugs
Co-occurring Psychosocial Health Disparities and ARV Medication Adherence among Indigent HIV-positive Patients who Use Drugs Steven P. Kurtz, Hilary L. Surratt and Mance E. Buttram Center for Applied Research
More informationChapter 3. Producing Data
Chapter 3 Producing Data Types of data collected Anecdotal data data collected haphazardly (not representative!!) Available data existing data (examples: internet, library, census bureau,.) Gather own
More informationBias. A systematic error (caused by the investigator or the subjects) that causes an incorrect (overor under-) estimate of an association.
Bias A systematic error (caused by the investigator or the subjects) that causes an incorrect (overor under-) estimate of an association. Here, random error is small, but systematic errors have led to
More informationLEADER Liraglutide and cardiovascular outcomes in type 2 diabetes
LEADER Liraglutide and cardiovascular outcomes in type 2 diabetes Presented at DSBS seminar on mediation analysis August 18 th Søren Rasmussen, Novo Nordisk. LEADER CV outcome study To determine the effect
More informationPiloting Treatment with IGF-1 in Phelan-McDermid Syndrome
Piloting Treatment with IGF-1 in Phelan-McDermid Syndrome Seaver Autism Center for Research and Treatment at Mount Sinai Principal Investigator: Alex Kolevzon, MD One Gustave L. Levy Place, Box 1230 New
More informationAllergan Not Applicable AGN A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose, Parallel
Peripheral Neuropathy Design, Dose Ranging Study of the Safety and Efficacy of AGN 203818 in Patients with Painful Diabetic 203818-004. A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Multiple
More informationUpdates in Therapeutics 2015: The Pharmacotherapy Preparatory Review & Recertification Course
Updates in Therapeutics 2015: The Pharmacotherapy Preparatory Review & Recertification Course Study Designs: Fundamentals and Interpretation Kevin M. Sowinski, Pharm.D., FCCP Purdue University, College
More informationUnderstandable Statistics
Understandable Statistics correlated to the Advanced Placement Program Course Description for Statistics Prepared for Alabama CC2 6/2003 2003 Understandable Statistics 2003 correlated to the Advanced Placement
More informationWARNING LETTER. Robert Essner Chairman and Chief Executive Officer Wyeth Pharmaceuticals Inc. P.O. Box 8299 Philadelphia, PA
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 TRANSMITTED BY FACSIMILE Robert Essner Chairman and Chief Executive Officer P.O. Box 8299 Philadelphia,
More informationUpdates from 2017 International Stroke Conferences
Updates from 2017 International Stroke Conferences Ravi Menon, MD Swedish Neuroscience Institute May 11, 2017 Seattle, WA 1 Disclosures No relevant financial disclosures Clinical trial involvement: Former
More informationGeneral Biostatistics Concepts
General Biostatistics Concepts Dongmei Li Department of Public Health Sciences Office of Public Health Studies University of Hawai i at Mānoa Outline 1. What is Biostatistics? 2. Types of Measurements
More informationReview+Practice. May 30, 2012
Review+Practice May 30, 2012 Final: Tuesday June 5 8:30-10:20 Venue: Sections AA and AB (EEB 125), sections AC and AD (EEB 105), sections AE and AF (SIG 134) Format: Short answer. Bring: calculator, BRAINS
More informationTENNESSEE STROKE REGISTRY QUARTERLY REPORT
TENNESSEE STROKE REGISTRY QUARTERLY REPORT Volume 1, Issue 3 September 2018 This report is published quarterly using data from the Tennessee Stroke Registry. Inside this report Data on diagnosis, gender
More informationLecture Outline Biost 517 Applied Biostatistics I. Statistical Goals of Studies Role of Statistical Inference
Lecture Outline Biost 517 Applied Biostatistics I Scott S. Emerson, M.D., Ph.D. Professor of Biostatistics University of Washington Statistical Inference Role of Statistical Inference Hierarchy of Experimental
More informationPurpose. Study Designs. Objectives. Observational Studies. Analytic Studies
Purpose Study Designs H.S. Teitelbaum, DO, PhD, MPH, FAOCOPM AOCOPM Annual Meeting Introduce notions of study design Clarify common terminology used with description and interpretation of information collected
More information